Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Induction of NF-kappaB, IkappaB-alpha, and iNOS in rat gastric mucosa during endotoxemia.

Helmer KS, Chang L, Cui Y, Mercer DW.

J Surg Res. 2002 May 1;104(1):46-52.

PMID:
11971677
5.

[Activation of nuclear factor-kappaB signaling pathway in rat gastric mucosa during stress ulceration].

Jia YT, Wei D, Chen XL, Xia ZF.

Zhonghua Shao Shang Za Zhi. 2006 Oct;22(5):351-4. Chinese.

PMID:
17283880
6.

16K prolactin induces NF-kappaB activation in pulmonary fibroblasts.

Macotela Y, Mendoza C, Corbacho AM, Cosío G, Eiserich JP, Zentella A, Martínez de la Escalera G, Clapp C.

J Endocrinol. 2002 Dec;175(3):R13-8.

7.

Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase-2.

Suliburk JW, Helmer KS, Gonzalez EA, Robinson EK, Mercer DW.

Surgery. 2005 Aug;138(2):134-40.

PMID:
16153419
8.

Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion.

Zhong C, Zhou Y, Liu H.

Anesthesiology. 2004 Mar;100(3):540-6.

PMID:
15108966
9.

Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.

Shin HM, Byung Hak Kim, Eun Yong Chung, Jung SH, Yeong Shik Kim, Kyung Rak Min, Kim Y.

Eur J Pharmacol. 2005 Oct 3;521(1-3):1-8. Epub 2005 Sep 23.

PMID:
16183054
10.
11.

Casein kinase II-mediated phosphorylation of NF-kappaB p65 subunit enhances inducible nitric-oxide synthase gene transcription in vivo.

Chantôme A, Pance A, Gauthier N, Vandroux D, Chenu J, Solary E, Jeannin JF, Reveneau S.

J Biol Chem. 2004 Jun 4;279(23):23953-60. Epub 2004 Mar 19.

12.

Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB.

Pingle SC, Sanchez JF, Hallam DM, Williamson AL, Maggirwar SB, Ramkumar V.

Mol Pharmacol. 2003 Jun;63(6):1238-47.

13.

Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.

Milligan SA, Owens MW, Grisham MB.

Arch Biochem Biophys. 1996 Nov 15;335(2):388-95.

PMID:
8914937
14.

Nuclear factor-kappaB is activated in intestinal mucosa during endotoxemia.

Pritts TA, Moon R, Fischer JE, Salzman AL, Hasselgren PO.

Arch Surg. 1998 Dec;133(12):1311-5.

PMID:
9865648
15.

Hepatic ischemia/reperfusion upregulates the susceptibility of hepatocytes to confer the induction of inducible nitric oxide synthase gene expression.

Yanagida H, Kaibori M, Yoshida H, Habara K, Yamada M, Kamiyama Y, Okumura T.

Shock. 2006 Aug;26(2):162-8.

PMID:
16878024
16.

Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappaB inactivation in RAW 264.7 macrophage cells.

Kim JB, Han AR, Park EY, Kim JY, Cho W, Lee J, Seo EK, Lee KT.

Biol Pharm Bull. 2007 Dec;30(12):2345-51.

17.

Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages.

Noguchi S, Nakatsuka M, Konishi H, Kamada Y, Chekir C, Kudo T.

Int Immunopharmacol. 2003 Sep;3(9):1335-44.

PMID:
12890431
18.

Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase expression by a novel compound, mercaptopyrazine, through suppression of nuclear factor-kappaB binding to DNA.

Lim S, Kang KW, Park SY, Kim SI, Choi YS, Kim ND, Lee KU, Lee HK, Pak YK.

Biochem Pharmacol. 2004 Aug 15;68(4):719-28.

PMID:
15276079
19.

Inducible nitric oxide synthase expression and nuclear factor-kappaB activation in alveolar type II cells in lung injury.

Toga H, Tobe T, Ueda Y, Yang GH, Osanai K, Ishigaki M, Okazaki H, Katsuda S, Takahashi K, Ohya N.

Exp Lung Res. 2001 Sep;27(6):485-504.

PMID:
11558966

Supplemental Content

Support Center